Business Editors
HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Oct. 24, 2006--Medical Action
Industries Inc. (NASDAQ/MDCI), a leading supplier of medical and
surgical disposable products, today announced that it was once again
selected by Forbes Magazine as one of the 200 best small public
companies in America. Paul D. Meringolo, Chief Executive Officer and
President of Medical Action, noted that "It is extremely gratifying to
receive this recognition for the sixth consecutive year, especially
given the extraordinary criteria, which includes sales growth,
earnings growth, and return on equity, over the past five years. Our
continuous selection over the past six years demonstrates our ability
to manage our business despite volatility in raw material costs and
general economic business conditions. We are extremely proud to have
delivered eleven consecutive years of record revenue and nine
consecutive years of record income."
Mr. Meringolo further clarified that "The recently announced
settlement between Medegen Medical Products and the United States
Equal Employment Opportunity Commission does not require any payment
be made by Medical Action. The settlement, which stems from activities
that allegedly occurred more than three years ago, was specifically
carved out of Medical Action's purchase of Medegen Medical Products."
Medical Action is a diversified manufacturer of disposable medical
devices. Its products are marketed primarily to acute care facilities
in domestic and certain international markets. Further, Medical Action
has expanded its target market to include physician, dental and
veterinary offices, out-patient surgery centers and long-term care
facilities. Medical Action is a leading manufacturer and distributor
of many of its products in the markets we compete in. Our products are
marketed through an extensive network of direct sales personnel and
independent distributors. Medical Action has preferred vendor
agreements with national distributors, as well as contracts with
nearly every major group purchasing alliance. The Company's common
stock trades on the NASDAQ Global Select Market under the symbol MDCI
and is included in the Russell 2000 Index.
This news release contains forward-looking statements that involve
risks and uncertainties regarding Medical Action's operations and
future results. Please see the Company's filings with the Securities
and Exchange Commission, including, without limitation, the Company's
Form 10-K and Form 10-Qs, which identify specific factors that would
cause actual results or events to differ materially from those
described in the forward-looking statements.
CONTACT: Medical Action Industries Inc.
Richard G. Satin, Vice President of Operations and
General Counsel
631-231-4600
SOURCE: Medical Action Industries Inc.